Applications of CRISPR-mediated induction of BDNF have been found to successfully restore corticostriatal connectivity in models of Huntington’s disease, and there is even evidence that they result in decreased neuronal loss and increased life-span [304]. This evidence concerns the gene BDNF and Huntington disease.